title: [Citalopram and Torsades de Pointes. A case report].
abstract: Inhibitors of serotonin uptake are drugs prescribed without recognised cardiovascular risk. The authors report a case of torsades de pointes following Citalopram ingestion. In this patient, the proof of reintroduction in a hospital environment resulted in prolongation of the QT interval. Screening of patients for acquired or congenital long QT intervals is therefore necessary before starting treatment with Citalopram.
authors.affiliation: Service de cardiologie, centre hospitalier René-Dubos, 6, avenue de l'lie-France, 95301 Pontoise.
authors.forename: C
authors.initials: C
authors.lastname: Meuleman
authors.forename: P
authors.initials: P
authors.lastname: Jourdain
authors.forename: M
authors.initials: M
authors.lastname: Bellorini
authors.forename: N
authors.initials: N
authors.lastname: Sadeg
authors.forename: J
authors.initials: J
authors.lastname: Loiret
authors.forename: N
authors.initials: N
authors.lastname: Guillard
authors.forename: B
authors.initials: B
authors.lastname: Thebault
authors.forename: F
authors.initials: F
authors.lastname: Funck
mesh_terms: D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000627:therapeutic use; D015283:Citalopram / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000150:complications; D008875:Middle Aged; D016171:Torsades de Pointes / Q000139:chemically induced*
chemical_list: D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram
vernacular_title: Citalopram et torsades de pointes. A propos d'un cas.